NCT06625775 2026-03-18Open-Label Study of BBO-10203 in Subjects With Advanced Solid TumorsTheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)Phase 1 Recruiting392 enrolled
NCT06257264 2026-03-05A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage TumorsBeOne MedicinesPhase 1 Recruiting258 enrolled